Journey Strategic Wealth »

Oramed Pharm shares owned by Journey Strategic Wealth

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by Journey Strategic Wealth from 13F filings

Historical chart of Journey Strategic Wealth investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by Journey Strategic Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by Journey Strategic Wealth

Quarter filed Position value Share count Share price at filing
2024-09-30 $30k 12k 2.44
2024-06-30 $28k 11k 2.57
2024-03-31 $31k 10k 2.92

More positions owned by Journey Strategic Wealth

Johnson & Johnson (JNJ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Pepsi (PEP)
Ishares Tr Esg Awr Msci Usa (ESGU)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Microsoft Corporation (MSFT)
Wisdomtree Tr Intl Qulty Div (IQDG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Invesco Actively Managed Exc Total Return (GTO)

View all positions for Journey Strategic Wealth

Top funds holding Oramed Pharm

BML Capital Management
Murchinson
Rathbones Brothers
Two Sigma Advisers
Renaissance Technologies
Bank of America Corporation
Two Sigma Investments
Susquehanna International
Connor, Clark & Lunn Investment Management
BlackRock
BlackRock
Squarepoint Ops
State Street Corporation
Jane Street
Dimensional Fund Advisors

View all funds holding Oramed Pharm